Protective effect of antioxidant ebselen (PZ51) on the cerebral cortex of stroke-prone spontaneously hypertensive rats

被引:21
作者
Sui, H
Wang, W
Wang, PH
Liu, LS
机构
[1] Peking Union Med Coll, Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Xicheng Distric, Peoples R China
[2] Peking Union Med Coll, Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Xicheng Distric, Peoples R China
关键词
ebselen (PZ51); stroke-prone spontaneously hypertensive rats; cortical neuron; nitric oxide; inducible nitric oxide synthase;
D O I
10.1291/hypres.28.249
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
An increase in reactive oxygen species has been shown to play a role in perpetuating hypertension and cerebral injury in stroke-prone spontaneously hypertensive rats (SHRsp). Lipid peroxidation in the cerebral cortex is much more intense in SHRsp after establishment of severe hypertension as compared to that in normotensive Wistar-Kyoto rats (WKY). Cortical neurons from SHRsp are more vulnerable to hypoxia and hyponutritional conditions. We sought to investigate whether long-term administration of seleno-glutathione peroxidase mimic ebselen (PZ51) would have a protective effect on cortical neurons in SHRsp, and, if so, the possible mechanisms of this effect. Twenty-two 8-week-old SHRsp were randomized into a PZ51 group and control group. Age-matched WKY were used as normal controls. We examined the levels of malonaldehyde (MDA) and nitric oxide (NO) in the cerebral cortex (CC) homogenate, detected the three isoforms of nitric oxide synthase (NOS) by Western blotting, and examined cortical neurons by transmission electron microscopy. The results showed that PZ51 treatment significantly decreased both MDA and NO in the CC, inhibited inducible nitric oxide synthase (iNOS) protein expression, and alleviated the damage to cortical neurons compared to the findings for the control group. In conclusion, the present study showed that PZ51 administration suppressed lipid peroxidation and inhibited iNOS protein expression in CC homogenate, and it was suggested that these mechanisms may play a role in the protective effects of PZ51 on cortical neurons of SHRsp.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 36 条
[21]   Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension [J].
McIntyre, M ;
Hamilton, CA ;
Rees, DD ;
Reid, JL ;
Dominiczak, AF .
HYPERTENSION, 1997, 30 (06) :1517-1524
[22]   Measurement of oxidative stress in stroke-prone spontaneously hypertensive rat brain using in vivo electron spin resonance spectroscopy [J].
Miyazaki, H ;
Shoji, H ;
Lee, MCI .
REDOX REPORT, 2002, 7 (05) :260-265
[23]  
MULLER A, 1985, BIOCHEM PHARMACOL, V34, P2691
[24]   Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice [J].
Namura, S ;
Nagata, I ;
Takami, S ;
Masayasu, H ;
Kikuchi, H .
STROKE, 2001, 32 (08) :1906-1911
[25]   ASSAY FOR LIPID PEROXIDES IN ANIMAL-TISSUES BY THIOBARBITURIC ACID REACTION [J].
OHKAWA, H ;
OHISHI, N ;
YAGI, K .
ANALYTICAL BIOCHEMISTRY, 1979, 95 (02) :351-358
[26]  
PAU AL, 2003, STROKE, V34, P2013
[27]   Anti-oxidant status and lipid peroxidation in patients with essential hypertension [J].
Russo, C ;
Olivieri, O ;
Girelli, D ;
Faccini, G ;
Zenari, ML ;
Lombardi, S ;
Corrocher, R .
JOURNAL OF HYPERTENSION, 1998, 16 (09) :1267-1271
[28]   A NOVEL BIOLOGICALLY-ACTIVE SELENO-ORGANIC COMPOUND .5. INHIBITION BY EBSELEN (PZ-51) OF RAT PERITONEAL NEUTROPHIL LIPOXYGENASE [J].
SAFAYHI, H ;
TIEGS, G ;
WENDEL, A .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (15) :2691-2694
[29]   Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion [J].
Tagami, M ;
Yamagata, K ;
Ikeda, K ;
Fujino, H ;
Nara, Y ;
Nakagawa, K ;
Kubota, A ;
Numano, F ;
Yamori, Y .
HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 22 (01) :23-29
[30]   Neuroprotective efficacy of ebselen, an anti-oxidant with antiinflammatory actions, in a rodent model of permanent middle cerebral artery occlusion [J].
Takasago, T ;
Peters, EE ;
Graham, DI ;
Masayasu, H ;
Macrae, IM .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (06) :1251-1256